ArticleCost effectiveness and resource allocation : C/E2021

Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only.

Thomas Ostermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.